Global Biologics Contract Manufacturing Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Biologics Contract Manufacturing market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Contract manufacturing is a type of outsourcing in which a company enters into an agreement or legal agreement for a product, part or component with another manufacturing company, who then uses that agreement or legal settlement of the product in its production process. This involves the manufacture of biopharmaceutical molecules, proteins, nucleic acids, blood components and vaccines developed from biological sources. These companies specialize in the production of molecules and provide different types of services such as development processes, analysis, and quality control.
This report is a detailed and comprehensive analysis for global Biologics Contract Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biologics Contract Manufacturing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Biologics Contract Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Biologics Contract Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Biologics Contract Manufacturing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biologics Contract Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biologics Contract Manufacturing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group, Samsung Biologics Co., Ltd., Thermo Fisher Scientific, Inc., Cambrex Corporation, Siegfried Holding AG, Fujifilm Holding Corporation, AbbVie, Inc., Boehringer Ingelheim, Recipharm Pharmaceuticals, WuXi Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biologics Contract Manufacturing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biologics Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biologics Contract Manufacturing, with revenue, gross margin, and global market share of Biologics Contract Manufacturing from 2020 to 2025.
Chapter 3, the Biologics Contract Manufacturing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Biologics Contract Manufacturing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologics Contract Manufacturing.
Chapter 13, to describe Biologics Contract Manufacturing research findings and conclusion.
Contract manufacturing is a type of outsourcing in which a company enters into an agreement or legal agreement for a product, part or component with another manufacturing company, who then uses that agreement or legal settlement of the product in its production process. This involves the manufacture of biopharmaceutical molecules, proteins, nucleic acids, blood components and vaccines developed from biological sources. These companies specialize in the production of molecules and provide different types of services such as development processes, analysis, and quality control.
This report is a detailed and comprehensive analysis for global Biologics Contract Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biologics Contract Manufacturing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Biologics Contract Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Biologics Contract Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Biologics Contract Manufacturing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biologics Contract Manufacturing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biologics Contract Manufacturing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza Group, Samsung Biologics Co., Ltd., Thermo Fisher Scientific, Inc., Cambrex Corporation, Siegfried Holding AG, Fujifilm Holding Corporation, AbbVie, Inc., Boehringer Ingelheim, Recipharm Pharmaceuticals, WuXi Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biologics Contract Manufacturing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Monoclonal Antibodies
- Recombinant Proteins
- Vaccines
- Molecular Therapy
- Others
- Medical Company
- Hospital
- Lonza Group
- Samsung Biologics Co., Ltd.
- Thermo Fisher Scientific, Inc.
- Cambrex Corporation
- Siegfried Holding AG
- Fujifilm Holding Corporation
- AbbVie, Inc.
- Boehringer Ingelheim
- Recipharm Pharmaceuticals
- WuXi Biologics
- Catalent, Inc.
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biologics Contract Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biologics Contract Manufacturing, with revenue, gross margin, and global market share of Biologics Contract Manufacturing from 2020 to 2025.
Chapter 3, the Biologics Contract Manufacturing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Biologics Contract Manufacturing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologics Contract Manufacturing.
Chapter 13, to describe Biologics Contract Manufacturing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biologics Contract Manufacturing by Type
1.3.1 Overview: Global Biologics Contract Manufacturing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Biologics Contract Manufacturing Consumption Value Market Share by Type in 2024
1.3.3 Monoclonal Antibodies
1.3.4 Recombinant Proteins
1.3.5 Vaccines
1.3.6 Molecular Therapy
1.3.7 Others
1.4 Global Biologics Contract Manufacturing Market by Application
1.4.1 Overview: Global Biologics Contract Manufacturing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Medical Company
1.4.3 Hospital
1.5 Global Biologics Contract Manufacturing Market Size & Forecast
1.6 Global Biologics Contract Manufacturing Market Size and Forecast by Region
1.6.1 Global Biologics Contract Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Biologics Contract Manufacturing Market Size by Region, (2020-2031)
1.6.3 North America Biologics Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.4 Europe Biologics Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Biologics Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.6 South America Biologics Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Biologics Contract Manufacturing Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Lonza Group
2.1.1 Lonza Group Details
2.1.2 Lonza Group Major Business
2.1.3 Lonza Group Biologics Contract Manufacturing Product and Solutions
2.1.4 Lonza Group Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Lonza Group Recent Developments and Future Plans
2.2 Samsung Biologics Co., Ltd.
2.2.1 Samsung Biologics Co., Ltd. Details
2.2.2 Samsung Biologics Co., Ltd. Major Business
2.2.3 Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Product and Solutions
2.2.4 Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Samsung Biologics Co., Ltd. Recent Developments and Future Plans
2.3 Thermo Fisher Scientific, Inc.
2.3.1 Thermo Fisher Scientific, Inc. Details
2.3.2 Thermo Fisher Scientific, Inc. Major Business
2.3.3 Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Product and Solutions
2.3.4 Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.4 Cambrex Corporation
2.4.1 Cambrex Corporation Details
2.4.2 Cambrex Corporation Major Business
2.4.3 Cambrex Corporation Biologics Contract Manufacturing Product and Solutions
2.4.4 Cambrex Corporation Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Cambrex Corporation Recent Developments and Future Plans
2.5 Siegfried Holding AG
2.5.1 Siegfried Holding AG Details
2.5.2 Siegfried Holding AG Major Business
2.5.3 Siegfried Holding AG Biologics Contract Manufacturing Product and Solutions
2.5.4 Siegfried Holding AG Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Siegfried Holding AG Recent Developments and Future Plans
2.6 Fujifilm Holding Corporation
2.6.1 Fujifilm Holding Corporation Details
2.6.2 Fujifilm Holding Corporation Major Business
2.6.3 Fujifilm Holding Corporation Biologics Contract Manufacturing Product and Solutions
2.6.4 Fujifilm Holding Corporation Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Fujifilm Holding Corporation Recent Developments and Future Plans
2.7 AbbVie, Inc.
2.7.1 AbbVie, Inc. Details
2.7.2 AbbVie, Inc. Major Business
2.7.3 AbbVie, Inc. Biologics Contract Manufacturing Product and Solutions
2.7.4 AbbVie, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 AbbVie, Inc. Recent Developments and Future Plans
2.8 Boehringer Ingelheim
2.8.1 Boehringer Ingelheim Details
2.8.2 Boehringer Ingelheim Major Business
2.8.3 Boehringer Ingelheim Biologics Contract Manufacturing Product and Solutions
2.8.4 Boehringer Ingelheim Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Boehringer Ingelheim Recent Developments and Future Plans
2.9 Recipharm Pharmaceuticals
2.9.1 Recipharm Pharmaceuticals Details
2.9.2 Recipharm Pharmaceuticals Major Business
2.9.3 Recipharm Pharmaceuticals Biologics Contract Manufacturing Product and Solutions
2.9.4 Recipharm Pharmaceuticals Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Recipharm Pharmaceuticals Recent Developments and Future Plans
2.10 WuXi Biologics
2.10.1 WuXi Biologics Details
2.10.2 WuXi Biologics Major Business
2.10.3 WuXi Biologics Biologics Contract Manufacturing Product and Solutions
2.10.4 WuXi Biologics Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 WuXi Biologics Recent Developments and Future Plans
2.11 Catalent, Inc.
2.11.1 Catalent, Inc. Details
2.11.2 Catalent, Inc. Major Business
2.11.3 Catalent, Inc. Biologics Contract Manufacturing Product and Solutions
2.11.4 Catalent, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Catalent, Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biologics Contract Manufacturing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Biologics Contract Manufacturing by Company Revenue
3.2.2 Top 3 Biologics Contract Manufacturing Players Market Share in 2024
3.2.3 Top 6 Biologics Contract Manufacturing Players Market Share in 2024
3.3 Biologics Contract Manufacturing Market: Overall Company Footprint Analysis
3.3.1 Biologics Contract Manufacturing Market: Region Footprint
3.3.2 Biologics Contract Manufacturing Market: Company Product Type Footprint
3.3.3 Biologics Contract Manufacturing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biologics Contract Manufacturing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Biologics Contract Manufacturing Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biologics Contract Manufacturing Consumption Value Market Share by Application (2020-2025)
5.2 Global Biologics Contract Manufacturing Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Biologics Contract Manufacturing Consumption Value by Type (2020-2031)
6.2 North America Biologics Contract Manufacturing Market Size by Application (2020-2031)
6.3 North America Biologics Contract Manufacturing Market Size by Country
6.3.1 North America Biologics Contract Manufacturing Consumption Value by Country (2020-2031)
6.3.2 United States Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
6.3.3 Canada Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
6.3.4 Mexico Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Biologics Contract Manufacturing Consumption Value by Type (2020-2031)
7.2 Europe Biologics Contract Manufacturing Consumption Value by Application (2020-2031)
7.3 Europe Biologics Contract Manufacturing Market Size by Country
7.3.1 Europe Biologics Contract Manufacturing Consumption Value by Country (2020-2031)
7.3.2 Germany Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.3 France Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.5 Russia Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.6 Italy Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biologics Contract Manufacturing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Biologics Contract Manufacturing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Biologics Contract Manufacturing Market Size by Region
8.3.1 Asia-Pacific Biologics Contract Manufacturing Consumption Value by Region (2020-2031)
8.3.2 China Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.3 Japan Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.4 South Korea Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.5 India Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.7 Australia Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Biologics Contract Manufacturing Consumption Value by Type (2020-2031)
9.2 South America Biologics Contract Manufacturing Consumption Value by Application (2020-2031)
9.3 South America Biologics Contract Manufacturing Market Size by Country
9.3.1 South America Biologics Contract Manufacturing Consumption Value by Country (2020-2031)
9.3.2 Brazil Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
9.3.3 Argentina Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biologics Contract Manufacturing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Biologics Contract Manufacturing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Biologics Contract Manufacturing Market Size by Country
10.3.1 Middle East & Africa Biologics Contract Manufacturing Consumption Value by Country (2020-2031)
10.3.2 Turkey Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
10.3.4 UAE Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Biologics Contract Manufacturing Market Drivers
11.2 Biologics Contract Manufacturing Market Restraints
11.3 Biologics Contract Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biologics Contract Manufacturing Industry Chain
12.2 Biologics Contract Manufacturing Upstream Analysis
12.3 Biologics Contract Manufacturing Midstream Analysis
12.4 Biologics Contract Manufacturing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biologics Contract Manufacturing by Type
1.3.1 Overview: Global Biologics Contract Manufacturing Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Biologics Contract Manufacturing Consumption Value Market Share by Type in 2024
1.3.3 Monoclonal Antibodies
1.3.4 Recombinant Proteins
1.3.5 Vaccines
1.3.6 Molecular Therapy
1.3.7 Others
1.4 Global Biologics Contract Manufacturing Market by Application
1.4.1 Overview: Global Biologics Contract Manufacturing Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Medical Company
1.4.3 Hospital
1.5 Global Biologics Contract Manufacturing Market Size & Forecast
1.6 Global Biologics Contract Manufacturing Market Size and Forecast by Region
1.6.1 Global Biologics Contract Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Biologics Contract Manufacturing Market Size by Region, (2020-2031)
1.6.3 North America Biologics Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.4 Europe Biologics Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Biologics Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.6 South America Biologics Contract Manufacturing Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Biologics Contract Manufacturing Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Lonza Group
2.1.1 Lonza Group Details
2.1.2 Lonza Group Major Business
2.1.3 Lonza Group Biologics Contract Manufacturing Product and Solutions
2.1.4 Lonza Group Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Lonza Group Recent Developments and Future Plans
2.2 Samsung Biologics Co., Ltd.
2.2.1 Samsung Biologics Co., Ltd. Details
2.2.2 Samsung Biologics Co., Ltd. Major Business
2.2.3 Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Product and Solutions
2.2.4 Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Samsung Biologics Co., Ltd. Recent Developments and Future Plans
2.3 Thermo Fisher Scientific, Inc.
2.3.1 Thermo Fisher Scientific, Inc. Details
2.3.2 Thermo Fisher Scientific, Inc. Major Business
2.3.3 Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Product and Solutions
2.3.4 Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.4 Cambrex Corporation
2.4.1 Cambrex Corporation Details
2.4.2 Cambrex Corporation Major Business
2.4.3 Cambrex Corporation Biologics Contract Manufacturing Product and Solutions
2.4.4 Cambrex Corporation Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Cambrex Corporation Recent Developments and Future Plans
2.5 Siegfried Holding AG
2.5.1 Siegfried Holding AG Details
2.5.2 Siegfried Holding AG Major Business
2.5.3 Siegfried Holding AG Biologics Contract Manufacturing Product and Solutions
2.5.4 Siegfried Holding AG Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Siegfried Holding AG Recent Developments and Future Plans
2.6 Fujifilm Holding Corporation
2.6.1 Fujifilm Holding Corporation Details
2.6.2 Fujifilm Holding Corporation Major Business
2.6.3 Fujifilm Holding Corporation Biologics Contract Manufacturing Product and Solutions
2.6.4 Fujifilm Holding Corporation Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Fujifilm Holding Corporation Recent Developments and Future Plans
2.7 AbbVie, Inc.
2.7.1 AbbVie, Inc. Details
2.7.2 AbbVie, Inc. Major Business
2.7.3 AbbVie, Inc. Biologics Contract Manufacturing Product and Solutions
2.7.4 AbbVie, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 AbbVie, Inc. Recent Developments and Future Plans
2.8 Boehringer Ingelheim
2.8.1 Boehringer Ingelheim Details
2.8.2 Boehringer Ingelheim Major Business
2.8.3 Boehringer Ingelheim Biologics Contract Manufacturing Product and Solutions
2.8.4 Boehringer Ingelheim Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Boehringer Ingelheim Recent Developments and Future Plans
2.9 Recipharm Pharmaceuticals
2.9.1 Recipharm Pharmaceuticals Details
2.9.2 Recipharm Pharmaceuticals Major Business
2.9.3 Recipharm Pharmaceuticals Biologics Contract Manufacturing Product and Solutions
2.9.4 Recipharm Pharmaceuticals Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Recipharm Pharmaceuticals Recent Developments and Future Plans
2.10 WuXi Biologics
2.10.1 WuXi Biologics Details
2.10.2 WuXi Biologics Major Business
2.10.3 WuXi Biologics Biologics Contract Manufacturing Product and Solutions
2.10.4 WuXi Biologics Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 WuXi Biologics Recent Developments and Future Plans
2.11 Catalent, Inc.
2.11.1 Catalent, Inc. Details
2.11.2 Catalent, Inc. Major Business
2.11.3 Catalent, Inc. Biologics Contract Manufacturing Product and Solutions
2.11.4 Catalent, Inc. Biologics Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Catalent, Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biologics Contract Manufacturing Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Biologics Contract Manufacturing by Company Revenue
3.2.2 Top 3 Biologics Contract Manufacturing Players Market Share in 2024
3.2.3 Top 6 Biologics Contract Manufacturing Players Market Share in 2024
3.3 Biologics Contract Manufacturing Market: Overall Company Footprint Analysis
3.3.1 Biologics Contract Manufacturing Market: Region Footprint
3.3.2 Biologics Contract Manufacturing Market: Company Product Type Footprint
3.3.3 Biologics Contract Manufacturing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biologics Contract Manufacturing Consumption Value and Market Share by Type (2020-2025)
4.2 Global Biologics Contract Manufacturing Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biologics Contract Manufacturing Consumption Value Market Share by Application (2020-2025)
5.2 Global Biologics Contract Manufacturing Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Biologics Contract Manufacturing Consumption Value by Type (2020-2031)
6.2 North America Biologics Contract Manufacturing Market Size by Application (2020-2031)
6.3 North America Biologics Contract Manufacturing Market Size by Country
6.3.1 North America Biologics Contract Manufacturing Consumption Value by Country (2020-2031)
6.3.2 United States Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
6.3.3 Canada Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
6.3.4 Mexico Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Biologics Contract Manufacturing Consumption Value by Type (2020-2031)
7.2 Europe Biologics Contract Manufacturing Consumption Value by Application (2020-2031)
7.3 Europe Biologics Contract Manufacturing Market Size by Country
7.3.1 Europe Biologics Contract Manufacturing Consumption Value by Country (2020-2031)
7.3.2 Germany Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.3 France Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.5 Russia Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
7.3.6 Italy Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biologics Contract Manufacturing Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Biologics Contract Manufacturing Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Biologics Contract Manufacturing Market Size by Region
8.3.1 Asia-Pacific Biologics Contract Manufacturing Consumption Value by Region (2020-2031)
8.3.2 China Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.3 Japan Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.4 South Korea Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.5 India Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
8.3.7 Australia Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Biologics Contract Manufacturing Consumption Value by Type (2020-2031)
9.2 South America Biologics Contract Manufacturing Consumption Value by Application (2020-2031)
9.3 South America Biologics Contract Manufacturing Market Size by Country
9.3.1 South America Biologics Contract Manufacturing Consumption Value by Country (2020-2031)
9.3.2 Brazil Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
9.3.3 Argentina Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biologics Contract Manufacturing Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Biologics Contract Manufacturing Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Biologics Contract Manufacturing Market Size by Country
10.3.1 Middle East & Africa Biologics Contract Manufacturing Consumption Value by Country (2020-2031)
10.3.2 Turkey Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
10.3.4 UAE Biologics Contract Manufacturing Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Biologics Contract Manufacturing Market Drivers
11.2 Biologics Contract Manufacturing Market Restraints
11.3 Biologics Contract Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Biologics Contract Manufacturing Industry Chain
12.2 Biologics Contract Manufacturing Upstream Analysis
12.3 Biologics Contract Manufacturing Midstream Analysis
12.4 Biologics Contract Manufacturing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Biologics Contract Manufacturing Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Biologics Contract Manufacturing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Biologics Contract Manufacturing Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Biologics Contract Manufacturing Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Lonza Group Company Information, Head Office, and Major Competitors
Table 6. Lonza Group Major Business
Table 7. Lonza Group Biologics Contract Manufacturing Product and Solutions
Table 8. Lonza Group Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Lonza Group Recent Developments andFuture Plans
Table 10. Samsung Biologics Co., Ltd. Company Information, Head Office, and Major Competitors
Table 11. Samsung Biologics Co., Ltd. Major Business
Table 12. Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Product and Solutions
Table 13. Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Samsung Biologics Co., Ltd. Recent Developments andFuture Plans
Table 15.ThermoFisher Scientific, Inc. Company Information, Head Office, and Major Competitors
Table 16.ThermoFisher Scientific, Inc. Major Business
Table 17.ThermoFisher Scientific, Inc. Biologics Contract Manufacturing Product and Solutions
Table 18.ThermoFisher Scientific, Inc. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Cambrex Corporation Company Information, Head Office, and Major Competitors
Table 20. Cambrex Corporation Major Business
Table 21. Cambrex Corporation Biologics Contract Manufacturing Product and Solutions
Table 22. Cambrex Corporation Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Cambrex Corporation Recent Developments andFuture Plans
Table 24. Siegfried Holding AG Company Information, Head Office, and Major Competitors
Table 25. Siegfried Holding AG Major Business
Table 26. Siegfried Holding AG Biologics Contract Manufacturing Product and Solutions
Table 27. Siegfried Holding AG Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Siegfried Holding AG Recent Developments andFuture Plans
Table 29.Fujifilm Holding Corporation Company Information, Head Office, and Major Competitors
Table 30.Fujifilm Holding Corporation Major Business
Table 31.Fujifilm Holding Corporation Biologics Contract Manufacturing Product and Solutions
Table 32.Fujifilm Holding Corporation Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33.Fujifilm Holding Corporation Recent Developments andFuture Plans
Table 34. AbbVie, Inc. Company Information, Head Office, and Major Competitors
Table 35. AbbVie, Inc. Major Business
Table 36. AbbVie, Inc. Biologics Contract Manufacturing Product and Solutions
Table 37. AbbVie, Inc. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. AbbVie, Inc. Recent Developments andFuture Plans
Table 39. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 40. Boehringer Ingelheim Major Business
Table 41. Boehringer Ingelheim Biologics Contract Manufacturing Product and Solutions
Table 42. Boehringer Ingelheim Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Boehringer Ingelheim Recent Developments andFuture Plans
Table 44. Recipharm Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 45. Recipharm Pharmaceuticals Major Business
Table 46. Recipharm Pharmaceuticals Biologics Contract Manufacturing Product and Solutions
Table 47. Recipharm Pharmaceuticals Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Recipharm Pharmaceuticals Recent Developments andFuture Plans
Table 49. WuXi Biologics Company Information, Head Office, and Major Competitors
Table 50. WuXi Biologics Major Business
Table 51. WuXi Biologics Biologics Contract Manufacturing Product and Solutions
Table 52. WuXi Biologics Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. WuXi Biologics Recent Developments andFuture Plans
Table 54. Catalent, Inc. Company Information, Head Office, and Major Competitors
Table 55. Catalent, Inc. Major Business
Table 56. Catalent, Inc. Biologics Contract Manufacturing Product and Solutions
Table 57. Catalent, Inc. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Catalent, Inc. Recent Developments andFuture Plans
Table 59. Global Biologics Contract Manufacturing Revenue (USD Million) by Players (2020-2025)
Table 60. Global Biologics Contract Manufacturing Revenue Share by Players (2020-2025)
Table 61. Breakdown of Biologics Contract Manufacturing by CompanyType (Tier 1,Tier 2, andTier 3)
Table 62. Market Position of Players in Biologics Contract Manufacturing, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 63. Head Office of Key Biologics Contract Manufacturing Players
Table 64. Biologics Contract Manufacturing Market: Company ProductTypeFootprint
Table 65. Biologics Contract Manufacturing Market: Company Product ApplicationFootprint
Table 66. Biologics Contract Manufacturing New Market Entrants and BarriersTo Market Entry
Table 67. Biologics Contract Manufacturing Mergers, Acquisition, Agreements, and Collaborations
Table 68. Global Biologics Contract Manufacturing Consumption Value (USD Million) byType (2020-2025)
Table 69. Global Biologics Contract Manufacturing Consumption Value Share byType (2020-2025)
Table 70. Global Biologics Contract Manufacturing Consumption ValueForecast byType (2026-2031)
Table 71. Global Biologics Contract Manufacturing Consumption Value by Application (2020-2025)
Table 72. Global Biologics Contract Manufacturing Consumption ValueForecast by Application (2026-2031)
Table 73. North America Biologics Contract Manufacturing Consumption Value byType (2020-2025) & (USD Million)
Table 74. North America Biologics Contract Manufacturing Consumption Value byType (2026-2031) & (USD Million)
Table 75. North America Biologics Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 76. North America Biologics Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 77. North America Biologics Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North America Biologics Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 79. Europe Biologics Contract Manufacturing Consumption Value byType (2020-2025) & (USD Million)
Table 80. Europe Biologics Contract Manufacturing Consumption Value byType (2026-2031) & (USD Million)
Table 81. Europe Biologics Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 82. Europe Biologics Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 83. Europe Biologics Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 84. Europe Biologics Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 85. Asia-Pacific Biologics Contract Manufacturing Consumption Value byType (2020-2025) & (USD Million)
Table 86. Asia-Pacific Biologics Contract Manufacturing Consumption Value byType (2026-2031) & (USD Million)
Table 87. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Region (2020-2025) & (USD Million)
Table 90. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Region (2026-2031) & (USD Million)
Table 91. South America Biologics Contract Manufacturing Consumption Value byType (2020-2025) & (USD Million)
Table 92. South America Biologics Contract Manufacturing Consumption Value byType (2026-2031) & (USD Million)
Table 93. South America Biologics Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 94. South America Biologics Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 95. South America Biologics Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 96. South America Biologics Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 97. Middle East & Africa Biologics Contract Manufacturing Consumption Value byType (2020-2025) & (USD Million)
Table 98. Middle East & Africa Biologics Contract Manufacturing Consumption Value byType (2026-2031) & (USD Million)
Table 99. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 100. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 101. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 102. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Global Key Players of Biologics Contract Manufacturing Upstream (Raw Materials)
Table 104. Global Biologics Contract ManufacturingTypical Customers
Table 1. Global Biologics Contract Manufacturing Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Table 2. Global Biologics Contract Manufacturing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Biologics Contract Manufacturing Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Biologics Contract Manufacturing Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Lonza Group Company Information, Head Office, and Major Competitors
Table 6. Lonza Group Major Business
Table 7. Lonza Group Biologics Contract Manufacturing Product and Solutions
Table 8. Lonza Group Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Lonza Group Recent Developments andFuture Plans
Table 10. Samsung Biologics Co., Ltd. Company Information, Head Office, and Major Competitors
Table 11. Samsung Biologics Co., Ltd. Major Business
Table 12. Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Product and Solutions
Table 13. Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Samsung Biologics Co., Ltd. Recent Developments andFuture Plans
Table 15.ThermoFisher Scientific, Inc. Company Information, Head Office, and Major Competitors
Table 16.ThermoFisher Scientific, Inc. Major Business
Table 17.ThermoFisher Scientific, Inc. Biologics Contract Manufacturing Product and Solutions
Table 18.ThermoFisher Scientific, Inc. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Cambrex Corporation Company Information, Head Office, and Major Competitors
Table 20. Cambrex Corporation Major Business
Table 21. Cambrex Corporation Biologics Contract Manufacturing Product and Solutions
Table 22. Cambrex Corporation Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Cambrex Corporation Recent Developments andFuture Plans
Table 24. Siegfried Holding AG Company Information, Head Office, and Major Competitors
Table 25. Siegfried Holding AG Major Business
Table 26. Siegfried Holding AG Biologics Contract Manufacturing Product and Solutions
Table 27. Siegfried Holding AG Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Siegfried Holding AG Recent Developments andFuture Plans
Table 29.Fujifilm Holding Corporation Company Information, Head Office, and Major Competitors
Table 30.Fujifilm Holding Corporation Major Business
Table 31.Fujifilm Holding Corporation Biologics Contract Manufacturing Product and Solutions
Table 32.Fujifilm Holding Corporation Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33.Fujifilm Holding Corporation Recent Developments andFuture Plans
Table 34. AbbVie, Inc. Company Information, Head Office, and Major Competitors
Table 35. AbbVie, Inc. Major Business
Table 36. AbbVie, Inc. Biologics Contract Manufacturing Product and Solutions
Table 37. AbbVie, Inc. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. AbbVie, Inc. Recent Developments andFuture Plans
Table 39. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 40. Boehringer Ingelheim Major Business
Table 41. Boehringer Ingelheim Biologics Contract Manufacturing Product and Solutions
Table 42. Boehringer Ingelheim Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Boehringer Ingelheim Recent Developments andFuture Plans
Table 44. Recipharm Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 45. Recipharm Pharmaceuticals Major Business
Table 46. Recipharm Pharmaceuticals Biologics Contract Manufacturing Product and Solutions
Table 47. Recipharm Pharmaceuticals Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Recipharm Pharmaceuticals Recent Developments andFuture Plans
Table 49. WuXi Biologics Company Information, Head Office, and Major Competitors
Table 50. WuXi Biologics Major Business
Table 51. WuXi Biologics Biologics Contract Manufacturing Product and Solutions
Table 52. WuXi Biologics Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. WuXi Biologics Recent Developments andFuture Plans
Table 54. Catalent, Inc. Company Information, Head Office, and Major Competitors
Table 55. Catalent, Inc. Major Business
Table 56. Catalent, Inc. Biologics Contract Manufacturing Product and Solutions
Table 57. Catalent, Inc. Biologics Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Catalent, Inc. Recent Developments andFuture Plans
Table 59. Global Biologics Contract Manufacturing Revenue (USD Million) by Players (2020-2025)
Table 60. Global Biologics Contract Manufacturing Revenue Share by Players (2020-2025)
Table 61. Breakdown of Biologics Contract Manufacturing by CompanyType (Tier 1,Tier 2, andTier 3)
Table 62. Market Position of Players in Biologics Contract Manufacturing, (Tier 1,Tier 2, andTier 3), Based on Revenue in 2024
Table 63. Head Office of Key Biologics Contract Manufacturing Players
Table 64. Biologics Contract Manufacturing Market: Company ProductTypeFootprint
Table 65. Biologics Contract Manufacturing Market: Company Product ApplicationFootprint
Table 66. Biologics Contract Manufacturing New Market Entrants and BarriersTo Market Entry
Table 67. Biologics Contract Manufacturing Mergers, Acquisition, Agreements, and Collaborations
Table 68. Global Biologics Contract Manufacturing Consumption Value (USD Million) byType (2020-2025)
Table 69. Global Biologics Contract Manufacturing Consumption Value Share byType (2020-2025)
Table 70. Global Biologics Contract Manufacturing Consumption ValueForecast byType (2026-2031)
Table 71. Global Biologics Contract Manufacturing Consumption Value by Application (2020-2025)
Table 72. Global Biologics Contract Manufacturing Consumption ValueForecast by Application (2026-2031)
Table 73. North America Biologics Contract Manufacturing Consumption Value byType (2020-2025) & (USD Million)
Table 74. North America Biologics Contract Manufacturing Consumption Value byType (2026-2031) & (USD Million)
Table 75. North America Biologics Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 76. North America Biologics Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 77. North America Biologics Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North America Biologics Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 79. Europe Biologics Contract Manufacturing Consumption Value byType (2020-2025) & (USD Million)
Table 80. Europe Biologics Contract Manufacturing Consumption Value byType (2026-2031) & (USD Million)
Table 81. Europe Biologics Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 82. Europe Biologics Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 83. Europe Biologics Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 84. Europe Biologics Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 85. Asia-Pacific Biologics Contract Manufacturing Consumption Value byType (2020-2025) & (USD Million)
Table 86. Asia-Pacific Biologics Contract Manufacturing Consumption Value byType (2026-2031) & (USD Million)
Table 87. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Region (2020-2025) & (USD Million)
Table 90. Asia-Pacific Biologics Contract Manufacturing Consumption Value by Region (2026-2031) & (USD Million)
Table 91. South America Biologics Contract Manufacturing Consumption Value byType (2020-2025) & (USD Million)
Table 92. South America Biologics Contract Manufacturing Consumption Value byType (2026-2031) & (USD Million)
Table 93. South America Biologics Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 94. South America Biologics Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 95. South America Biologics Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 96. South America Biologics Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 97. Middle East & Africa Biologics Contract Manufacturing Consumption Value byType (2020-2025) & (USD Million)
Table 98. Middle East & Africa Biologics Contract Manufacturing Consumption Value byType (2026-2031) & (USD Million)
Table 99. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Application (2020-2025) & (USD Million)
Table 100. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Application (2026-2031) & (USD Million)
Table 101. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Country (2020-2025) & (USD Million)
Table 102. Middle East & Africa Biologics Contract Manufacturing Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Global Key Players of Biologics Contract Manufacturing Upstream (Raw Materials)
Table 104. Global Biologics Contract ManufacturingTypical Customers
LIST OF FIGURES
Figure 1. Biologics Contract Manufacturing Picture
Figure 2. Global Biologics Contract Manufacturing Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Biologics Contract Manufacturing Consumption Value Market Share byType in 2024
Figure 4. Monoclonal Antibodies
Figure 5. Recombinant Proteins
Figure 6. Vaccines
Figure 7. MolecularTherapy
Figure 8. Others
Figure 9. Global Biologics Contract Manufacturing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 10. Biologics Contract Manufacturing Consumption Value Market Share by Application in 2024
Figure 11. Medical Company Picture
Figure 12. Hospital Picture
Figure 13. Global Biologics Contract Manufacturing Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Biologics Contract Manufacturing Consumption Value andForecast (2020-2031) & (USD Million)
Figure 15. Global Market Biologics Contract Manufacturing Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Biologics Contract Manufacturing Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Biologics Contract Manufacturing Consumption Value Market Share by Region in 2024
Figure 18. North America Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 23. CompanyThree Recent Developments andFuture Plans
Figure 24. Global Biologics Contract Manufacturing Revenue Share by Players in 2024
Figure 25. Biologics Contract Manufacturing Market Share by CompanyType (Tier 1,Tier 2, andTier 3) in 2024
Figure 26. Market Share of Biologics Contract Manufacturing by Player Revenue in 2024
Figure 27.Top 3 Biologics Contract Manufacturing Players Market Share in 2024
Figure 28.Top 6 Biologics Contract Manufacturing Players Market Share in 2024
Figure 29. Global Biologics Contract Manufacturing Consumption Value Share byType (2020-2025)
Figure 30. Global Biologics Contract Manufacturing Market ShareForecast byType (2026-2031)
Figure 31. Global Biologics Contract Manufacturing Consumption Value Share by Application (2020-2025)
Figure 32. Global Biologics Contract Manufacturing Market ShareForecast by Application (2026-2031)
Figure 33. North America Biologics Contract Manufacturing Consumption Value Market Share byType (2020-2031)
Figure 34. North America Biologics Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Biologics Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Biologics Contract Manufacturing Consumption Value Market Share byType (2020-2031)
Figure 40. Europe Biologics Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Biologics Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 43.France Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Biologics Contract Manufacturing Consumption Value Market Share byType (2020-2031)
Figure 48. Asia-Pacific Biologics Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Biologics Contract Manufacturing Consumption Value Market Share by Region (2020-2031)
Figure 50. China Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 53. India Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Biologics Contract Manufacturing Consumption Value Market Share byType (2020-2031)
Figure 57. South America Biologics Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Biologics Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Biologics Contract Manufacturing Consumption Value Market Share byType (2020-2031)
Figure 62. Middle East & Africa Biologics Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Biologics Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 64.Turkey Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 67. Biologics Contract Manufacturing Market Drivers
Figure 68. Biologics Contract Manufacturing Market Restraints
Figure 69. Biologics Contract Manufacturing MarketTrends
Figure 70. PortersFiveForces Analysis
Figure 71. Biologics Contract Manufacturing Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Biologics Contract Manufacturing Picture
Figure 2. Global Biologics Contract Manufacturing Consumption Value byType, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Biologics Contract Manufacturing Consumption Value Market Share byType in 2024
Figure 4. Monoclonal Antibodies
Figure 5. Recombinant Proteins
Figure 6. Vaccines
Figure 7. MolecularTherapy
Figure 8. Others
Figure 9. Global Biologics Contract Manufacturing Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 10. Biologics Contract Manufacturing Consumption Value Market Share by Application in 2024
Figure 11. Medical Company Picture
Figure 12. Hospital Picture
Figure 13. Global Biologics Contract Manufacturing Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Biologics Contract Manufacturing Consumption Value andForecast (2020-2031) & (USD Million)
Figure 15. Global Market Biologics Contract Manufacturing Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Biologics Contract Manufacturing Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Biologics Contract Manufacturing Consumption Value Market Share by Region in 2024
Figure 18. North America Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 23. CompanyThree Recent Developments andFuture Plans
Figure 24. Global Biologics Contract Manufacturing Revenue Share by Players in 2024
Figure 25. Biologics Contract Manufacturing Market Share by CompanyType (Tier 1,Tier 2, andTier 3) in 2024
Figure 26. Market Share of Biologics Contract Manufacturing by Player Revenue in 2024
Figure 27.Top 3 Biologics Contract Manufacturing Players Market Share in 2024
Figure 28.Top 6 Biologics Contract Manufacturing Players Market Share in 2024
Figure 29. Global Biologics Contract Manufacturing Consumption Value Share byType (2020-2025)
Figure 30. Global Biologics Contract Manufacturing Market ShareForecast byType (2026-2031)
Figure 31. Global Biologics Contract Manufacturing Consumption Value Share by Application (2020-2025)
Figure 32. Global Biologics Contract Manufacturing Market ShareForecast by Application (2026-2031)
Figure 33. North America Biologics Contract Manufacturing Consumption Value Market Share byType (2020-2031)
Figure 34. North America Biologics Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Biologics Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Biologics Contract Manufacturing Consumption Value Market Share byType (2020-2031)
Figure 40. Europe Biologics Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Biologics Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 43.France Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Biologics Contract Manufacturing Consumption Value Market Share byType (2020-2031)
Figure 48. Asia-Pacific Biologics Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Biologics Contract Manufacturing Consumption Value Market Share by Region (2020-2031)
Figure 50. China Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 53. India Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Biologics Contract Manufacturing Consumption Value Market Share byType (2020-2031)
Figure 57. South America Biologics Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Biologics Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Biologics Contract Manufacturing Consumption Value Market Share byType (2020-2031)
Figure 62. Middle East & Africa Biologics Contract Manufacturing Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Biologics Contract Manufacturing Consumption Value Market Share by Country (2020-2031)
Figure 64.Turkey Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Biologics Contract Manufacturing Consumption Value (2020-2031) & (USD Million)
Figure 67. Biologics Contract Manufacturing Market Drivers
Figure 68. Biologics Contract Manufacturing Market Restraints
Figure 69. Biologics Contract Manufacturing MarketTrends
Figure 70. PortersFiveForces Analysis
Figure 71. Biologics Contract Manufacturing Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
